Medicare Enrolled

Chasity Brock, NP-C

Q: Does Brock receive payments from pharmaceutical companies?

Yes. Brock received a total of $5,840 from 40 companies across 352 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

Q: What does Data Coverage mean?

Data Coverage (currently High for Brock) measures how much public federal data is available about a provider. It is not a quality rating. A Very High or High level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A Low or Moderate level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative.

Nurse Practitioner - Family · Bremen, GA

222 GORDON ST, Bremen, GA 30110

7705371234

Registered in NPPES since 2013

NPI: 1407291925 verify on NPPES ↗

High

DATA COVERAGE

Data in 3 of 4 federal sources

Measures public federal data availability — not provider quality

Informational, not a quality rating. This page presents federal public records about Brock from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →

Are you Brock? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Brock

Chasity Brock is a nurse practitioner - family in Bremen, GA, with 13 years of NPI registration.

Between the years covered by Open Payments, Brock received a total of $5,840 from 40 pharmaceutical and/or device companies across 352 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Brock is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years of NPI registration $5,840 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗

$5,840

Total received (2021-2024)

Avg $1,460/year across 4 years

Top 4% in GA for nurse practitioner - family

A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.

Companies

352

Payment records

Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024

$1,645

2023

$975

2022

$1,341

2021

$1,879

Payments by company (2024)

ABBVIE INC.

$806

PFIZER INC.

$248

Novo Nordisk Inc

$134

Amgen Inc.

$74

Astellas Pharma US Inc

$60

Lilly USA, LLC

$58

SHIELD THERAPEUTICS INC

$46

AstraZeneca Pharmaceuticals LP

$34

Salix Pharmaceuticals, a division of Bausch Health US, LLC

$33

Takeda Pharmaceuticals U.S.A., Inc.

$31

Sumitomo Pharma America, Inc.

$30

Lundbeck LLC

$18

Otsuka America Pharmaceutical, Inc.

$17

Novartis Pharmaceuticals Corporation

$15

Phathom Pharmaceuticals, Inc.

$15

Currax Pharmaceuticals LLC

$14

GlaxoSmithKline, LLC.

$13

Top 3 companies account for 72.2% of 2024 payments

All-time payments by company (2021-2024) ›

ABBVIE INC.

$1,236

Novo Nordisk Inc

$766

Lilly USA, LLC

$451

PFIZER INC.

$414

Amgen Inc.

$371

AbbVie Inc.

$308

AstraZeneca Pharmaceuticals LP

$243

GlaxoSmithKline, LLC.

$232

Amarin Pharma Inc.

$213

Otsuka America Pharmaceutical, Inc.

$146

Astellas Pharma US Inc

$129

Novartis Pharmaceuticals Corporation

$128

SANOFI-AVENTIS U.S. LLC

$126

Takeda Pharmaceuticals U.S.A., Inc.

$108

Lundbeck LLC

$104

Biohaven Pharmaceuticals, Inc.

$97

Salix Pharmaceuticals, a division of Bausch Health US, LLC

$91

Supernus Pharmaceuticals, Inc.

$69

Boehringer Ingelheim Pharmaceuticals, Inc.

$58

Allergan, Inc.

$56

Paratek Pharmaceuticals, Inc.

$55

Janssen Pharmaceuticals, Inc

$49

Covis Pharma GmBH

$48

SHIELD THERAPEUTICS INC

$46

Shield Therapeutics Inc

$40

Sumitomo Pharma America, Inc.

$30

Merck Sharp & Dohme LLC

$24

Ironshore Pharmaceuticals Inc.

$22

Eisai Inc.

$17

Amneal Pharmaceuticals LLC

$17

Mylan Specialty L.P.

$16

LINUS HEALTH, INC.

$16

Sunovion Pharmaceuticals Inc.

$16

Phathom Pharmaceuticals, Inc.

$15

Azurity Pharmaceuticals, Inc.

$14

Dynavax Technologies Corporation

$14

Acella Pharmaceuticals, LLC

$14

Currax Pharmaceuticals LLC

$14

Esperion Therapeutics, Inc.

$13

Teva Pharmaceuticals USA, Inc.

$13

Top 3 companies account for 42.0% of all-time payments

Associated products mentioned in payments ›

ACCRUFER · AJOVY · ALVESCO · Adthyza · Aimovig · BEXSERO · BOTOX · BREZTRI · CONTRAVE · CORE COGNITIVE EVALUATION · CREON · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · GEMTESA · Heplisav-B · INVEGA SUSTENNA · JANUMET · JARDIANCE · JORNAY PM · LEQVIO · LINZESS · MOUNJARO · MYRBETRIQ · NEXLETOL · NP Thyroid 60 · NURTEC ODT · NUZYRA · ORILISSA · Otezla · Ozempic · PREMARIN · PREVNAR 20 · QELBREE · QULIPTA · RELISTOR · REXULTI · RYBELSUS · Rybelsus · SOLIQUA 100/33 · SPRAVATO · Saxenda · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULICITY · UBRELVY · UNITHROID · VIBERZI · VOQUEZNA · VRAYLAR · VYEPTI · Vascepa · Veozah · Wegovy · XIFAXAN · Yupelri · ZEPBOUND

Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Looking for a nurse practitioner - family in Bremen?
Compare family nurse practitioners in the Bremen area by procedure volume, costs, and industry payment transparency.

Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners in nearby ZIP areas

228

County median income

$65,016

Nearest hospital to ZIP centroid (approximate)

HIGGINS GENERAL HOSPITAL
0.0 mi

Data Sources

Provider Registry	✓ NPPES	NPPES snapshot; verify current record
Medicare Enrollment	✓ PECOS	PECOS snapshot
Practice Data	— No data	N/A
Industry Payments	✓ Open Payments	CY 2024
Disciplinary History	— Not included	N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Brock is a nurse practitioner - family.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Brock receive payments from pharmaceutical companies?

Yes. Brock received a total of $5,840 from 40 companies across 352 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

What does Data Coverage mean?

Data Coverage (currently High for Brock) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →

Is this data up to date?

Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city

Family Nurse Practitioners in Bremen

Browse family nurse practitioners in Bremen ranked by procedure volume and transparency data.

Highest volume

Top Family Nurse Practitioners in GA

Family nurse practitioners ranked by total Medicare services performed statewide.

Industry payments

Pharma Payments to Family Nurse Practitioners in GA

Which GA family nurse practitioners receive the most from drug and device companies.

By company

ABBVIE INC. Payments to Doctors

See all physicians who received payments from ABBVIE INC.

By company

Novo Nordisk Inc Payments to Doctors

See all physicians who received payments from Novo Nordisk Inc.

By company

Lilly USA, LLC Payments to Doctors

See all physicians who received payments from Lilly USA, LLC.

About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology